Could a daily probiotic capsule tame irritable bowel syndrome?

NCT ID NCT06687720

Completed Disease control Sponsor: NovoBliss Research Pvt Ltd Source: ClinicalTrials.gov ↗

First seen Jul 31, 2026 · Last updated Jul 31, 2026

Summary

This trial tests whether an oral probiotic supplement called MetBroma can safely reduce symptoms of irritable bowel syndrome (IBS) and improve quality of life. Adults aged 18 to 60 with an IBS diagnosis will take the probiotic capsule twice a day, and researchers will track changes in symptoms, lifestyle impact, and blood markers like protein levels. The study is small and early-stage, so it aims to gather initial evidence on whether this approach is worth pursuing.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: MetBroma, an oral probiotic supplement taken as a slow-release capsule twice daily
What this could lead to: If it works, this probiotic could offer a simple, drug-free way to manage IBS symptoms and improve daily life for people with the condition.
What could go wrong: This is a very small, early-stage study with only 18 participants, so results may not apply broadly. Probiotics can also cause mild digestive upset in some people.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IRRITABLE BOWEL SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

irritable bowel syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

IRRITABLE BOWEL SYNDROME

Contacts and locations

Locations

NovoBliss Research Pvt Ltd

Ahmedabad, Gujarat, 382481, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.